Literature DB >> 32040657

NKp46+ lamina propria natural killer cells undergo metabolic reprogramming in a mouse experimental colitis model.

Hongjian Zhou1, Xingwang Xie1, Bin Jiang1, Chao Ke2.   

Abstract

OBJECTIVE: Both innate and adaptive immune system play important roles in the onset and progression of inflammatory bowel diseases (IBDs). However, the significance of natural killer (NK) cells for IBDs remains unclear. To understand the biology of colonic lamina propria natural killer (LPNK) cells in IBDs, we characterized LPNK cell metabolism in a murine acute colitis model.
METHODS: C57BL/6J mice were fed with 3% dextran sulfate sodium to establish the acute colitis model. Colonic LPNK cells were isolated from mice through flow cytometry. The expression of metabolic genes in LPNK cells was analyzed by transcriptome sequencing and quantitative RT-PCR. Glucose uptake, Seahorse assay, and ATP assay were conducted to assess the metabolic status of LPNK cells. Phos-flow assay was performed to evaluate cell signaling pathways in LPNK cells. In vitro stimulation and cytotoxicity assay were conducted to measure the function of LPNK cells.
RESULTS: In acute colitis, LPNK cells upregulated the expression of genes related to glycolysis and oxidative phosphorylation (oxphos), and enhanced glucose uptake capability. Intracellular ATP production, glycolysis and oxphos in LPNK cells were also promoted in acute colitis. mTORC1 signaling was essential for the metabolic reprogramming in LPNK cells in acute colitis. Although LPNK cells of diseased mice exhibited equivalent cytokine profile to normal LPNK cells upon stimulation with phorbol ester or IL-2, LPNK cells of diseased mice were more cytotoxic to target cells than normal LPNK cells.
CONCLUSIONS: LPNK cells undergo metabolic reprogramming which might be a response to upcoming microbial infection in acute colitis.

Entities:  

Keywords:  Glycolysis; Inflammatory bowel diseases; Metabolism; Natural killer cells; Oxidative phosphorylation; mTORC1

Mesh:

Substances:

Year:  2020        PMID: 32040657     DOI: 10.1007/s00011-020-01324-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  28 in total

Review 1.  The B-cell system in inflammatory bowel disease.

Authors:  Per Brandtzaeg; Hege S Carlsen; Trond S Halstensen
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 2.  mTOR signalling and cellular metabolism are mutual determinants in cancer.

Authors:  Dirk Mossmann; Sujin Park; Michael N Hall
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

3.  Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.

Authors:  Sinéad E Keating; Vanessa Zaiatz-Bittencourt; Roisín M Loftus; Ciara Keane; Kiva Brennan; David K Finlay; Clair M Gardiner
Journal:  J Immunol       Date:  2016-02-12       Impact factor: 5.422

4.  Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment.

Authors:  A W Steel; C M Mela; J O Lindsay; B G Gazzard; M R Goodier
Journal:  Aliment Pharmacol Ther       Date:  2010-10-29       Impact factor: 8.171

5.  Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

Authors:  Tetsuro Takayama; Nobuhiko Kamada; Hiroshi Chinen; Susumu Okamoto; Mina T Kitazume; Jonathan Chang; Yumi Matuzaki; Sadafumi Suzuki; Akira Sugita; Kazutaka Koganei; Tadakazu Hisamatsu; Takanori Kanai; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2010-06-01       Impact factor: 22.682

6.  A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties.

Authors:  Aline Van Acker; Konrad Gronke; Aindrila Biswas; Liesbet Martens; Yvan Saeys; Jessica Filtjens; Sylvie Taveirne; Els Van Ammel; Tessa Kerre; Patrick Matthys; Tom Taghon; Bart Vandekerckhove; Jean Plum; Ildiko Rita Dunay; Andreas Diefenbach; Georges Leclercq
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

7.  Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.

Authors:  Naoko Satoh-Takayama; Christian A J Vosshenrich; Sarah Lesjean-Pottier; Shinichiro Sawa; Matthias Lochner; Frederique Rattis; Jean-Jacques Mention; Kader Thiam; Nadine Cerf-Bensussan; Ofer Mandelboim; Gerard Eberl; James P Di Santo
Journal:  Immunity       Date:  2008-12-11       Impact factor: 31.745

8.  Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis.

Authors:  Masaru Shimamoto; Yoshitaka Ueno; Shinji Tanaka; Toshiko Onitake; Rie Hanaoka; Kyoko Yoshioka; Tsuyoshi Hatakeyama; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

9.  TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.

Authors:  Sébastien Viel; Antoine Marçais; Fernando Souza-Fonseca Guimaraes; Roisin Loftus; Jessica Rabilloud; Morgan Grau; Sophie Degouve; Sophia Djebali; Amélien Sanlaville; Emily Charrier; Jacques Bienvenu; Julien C Marie; Christophe Caux; Jacqueline Marvel; Liam Town; Nicholas D Huntington; Laurent Bartholin; David Finlay; Mark J Smyth; Thierry Walzer
Journal:  Sci Signal       Date:  2016-02-16       Impact factor: 8.192

Review 10.  Human Gut-Associated Natural Killer Cells in Health and Disease.

Authors:  Alessandro Poggi; Roberto Benelli; Roberta Venè; Delfina Costa; Nicoletta Ferrari; Francesca Tosetti; Maria Raffaella Zocchi
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.